Browse drugs

…s-matched umbilical cord blood transplant, with ciclosporin and mycophenolate mofetil as GvHD prophylaxis. Post-transplant, he developed grade 3 skin…

…mpliance with MHRA guidance.Conclusion This audit shows the ICB Valproate Dashboard is a valuable regional tool, but has significant limi…

…oss Australia, Hong Kong and Chinese Mainland were analysed for aspartame, sucralose, saccharin and P-80 levels in stool, urine and serum…

…icantly fewer SE compared with oxybutynin (solifenacin p=0.020, mirabegron p=0.025).Conclusions This study shows that oxybutynin and tolte…

…Background Combination immunotherapies such as atezolizumab plus bevacizumab (Atez/Bev) and durvalumab plus tremelimumab (D…

… −1.26, leptin −1.01, respectively) and at admission after TBI (leptin −1.51, visfatin −1.44, adiponectin −1.51, and resistin −1.29, a…

…III randomised controlled trials (RCTs) evaluating ranibizumab, brolucizumab, aflibercept, and faricimab in nAMD. Baseline characteristics i…

…entified, of which 149 (7.5%) involved herbal or food products: apixaban 42 (28.2%), dabigatran 42 (28.2%), edoxaban 23 (15.4%), rivarox…

…eatments, more than half were inappropriate: the first doses of gentamicin were too low (51%), while in a smaller portion (15%) the first …

…everity, and management of irAEs in melanoma patients receiving ipilimumab–nivolumab therapy.Material and Methods A retrospective observat…

…mepromazine (14.5%), olanzapine (12.7%), quetiapine (10.4%) and clothiapine (9%). Point out that 59.09% of residents take one antipsychotic…

…have doubled progression-free survival. Approved agents include abemaciclib, palbociclib, and ribociclib. In the MONARCH 2 trial, abemacicl…